Patient & Survivor Care
Conference Coverage
WISP: Early data provide further support for ISDO in women at high OC risk
HONOLULU – RRSO or ISDO each lead to significant reductions in cancer distress, but regret is greater with RRSO,...
Conference Coverage
Preliminary data show similar declines in worry, low regret with RRSO and RRS/RRO
HONOLULU – Early findings from the TUBA trial suggest similar declines in worry among women with BRCA1/2 mutations who undergo risk-reducing...
News
‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patients
However, there was no difference versus controls in goal-concordant care or peacefulness at end of life.
Conference Coverage
MI, strokes spike during 30 days after cancer diagnosis
HONOLULU – During the first 30 days after a cancer diagnosis, the incidence of an MI or stroke jumped nearly 500%.
Conference Coverage
KD025 produces durable responses in patients with cGVHD
HOUSTON – Many responses have lasted 20 weeks or more, and durability data are still maturing.
From the Journals
Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancer
Sperm count and concentration remained stable or increased in patients with clinical stage I testicular cancer who underwent unilateral...
Conference Coverage
Diet appears to play an important role in response to anti-PD-1 cancer immunotherapy
Diet appears to affect response to anti-PD-1 cancer immunotherapy, likely by its effect on the gut microbiome.
Hard Questions
Charity case
I deliver a lot of bad news in oncology, but I usually get to blame the disease. What I hate perhaps even more is the other type of bad news: We...
From the Journals
AHA: Consider obesity as CVD risk factor in children
The updated AHA scientific statement is aimed at pediatric cardiologists and physicians who care for at-risk pediatric patients.
From the Journals
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients
However, the reduction lost significance if treatment with rivaroxaban was halted.
Conference Coverage
ADT harms likely limited to men with CV comorbidities
WASHINGTON – Androgen deprivation therapy improves survival for men with high-risk cancers, but those with comorbid cardiovascular disease may be...